You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Eli
since
auto-detected in 141 stories
2 days ago
There are now positive results from five late-stage trials on retatrutide, which Lilly is positioning as the next pillar of its obesity portfolio.
6 days ago
The market for psychedelic drugs to treat mental health conditions gets a big buy signal ⊕
Eli Lilly's acquisition of psychedelic drug maker AtaiBeckley extends Big Pharma's embrace of a stigmatized class of medications for treating mental health.
9 days ago
Eli Lilly is reinventing the pharma business ○
The world’s largest drugmaker is betting big on preventive medicines—and learning from big tech
Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion as experimental treatments gain traction ⊕
The deal for AtaiBeckley gives Lilly access to experimental drugs based on DMT and MDMA.
18 days ago
Call of My Life review – bright and breezy Nigerian call-centre romcom is just right for summer ⊕⊕
Uzoamaka Power’s broken-hearted, lovable worker falls for a charming customer in this delightful, deftly written tale
Here is a delightful Nigerian romcom, in which Soluchi, or “Sol” (played by Uzoama…
26 days ago
Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities ○
Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC has learned.
51 days ago
Eli Manning weighs in on Giants QB Jaxson Dart's Trump rally fallout ○
found
Eli Manning spoke about political activities from athletes after Giants QB Jaxson Dart introduced President Donald Trump at a rally.
Eli Manning's private equity firm acquires licensing company for NFL Flag in bet on youth sports ⊖
Eli Manning's Brand Velocity Capital announced a deal to acquire youth sports company RCX amid congressional bill to ban private equity from youth sports.
52 days ago
Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas ⊕
Eli Lilly's new top dealmaker explains how the company changed its approach to M&A now that it's the most valuable pharmaceutical company in the world.
60 days ago
Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals ⊕
The deals are part of Eli Lilly’s effort to expand into infectious disease research and development.